At a glance
- Originator GlaxoSmithKline
- Class Antihyperglycaemics; Benzoxazoles; Small molecules
- Mechanism of Action Peroxisome proliferator-activated receptor alpha agonists; Peroxisome proliferator-activated receptor gamma agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Type 2 diabetes mellitus
Most Recent Events
- 24 Jan 2001 SmithKline Beecham has merged with Glaxo Wellcome to form GlaxoSmithKline
- 25 Jan 2000 Preclinical development for Type-2 diabetes mellitus in United Kingdom (Unknown route)